Back to matchesWe found a matchYour institution may have rights to this item. Sign in to continue.TitleA phase I trial to determine safety and pharmacokinetics of ASLAN002, an oral MET superfamily kinase inhibitor, in patients with advanced or metastatic solid cancers.AuthorsRoohullah, Aflah; Cooper, Adam; Lomax, Anna J.; Aung, Jennifer; Barge, Alan; Chow, Lilian; McHale, Mark; Desai, Jayesh; Whittle, James R.; Tran, Ben; de Souza, Paul; Horvath, Lisa G.PublicationInvestigational New Drugs, 2018, Vol 36, Issue 5, p886ISSN0167-6997Publication typeArticleDOI10.1007/s10637-018-0588-7